Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis

The main aim of this study is to compare the 2 medications denosumab and zoledronic acid for patients with beta-thalassemia major induced osteoporosis. Patients with B-thalassemia major induced osteoporosis will undergo baseline assessment of the bone densitometry by bone density (DEXA) scan as a st...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Medicine (Baltimore)
Auteurs principaux: Yassin, Mohamed A., Abdel Rahman, Mohamed O., Hamad, Anas A., Poil, Abdul Razzakh, Abdelrazek, Mohamed T., Hussein, Radwa M., Kassem, Nancy A., Fadul, Afraa M., Elkourashy, Sarah A., Nashwan, Abdulqadir J.
Format: Artigo
Langue:Inglês
Publié: Lippincott Williams & Wilkins 2020
Sujets:
4800
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7748343/
https://ncbi.nlm.nih.gov/pubmed/33371098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000023637
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires